Eisai EMEA
Alix O'Donnell holds a Master’s Degree in Genes, Drugs and Stem Cells from Imperial College London and a Bachelor’s Degree in Genetics from Trinity College Dublin. Currently serving as a Senior Global Brand Manager in Oncology at Eisai EMEA since December 2021, Alix previously occupied the role of Global Brand Manager in the same division. Prior experience includes a position as Commercial Strategy Manager Oncology at Pfizer from October 2016 to December 2021, along with roles as Network and Sales Specialist in Respiratory and Graduate Trainee in Inflammation and Immunology.
This person is not in any offices
Eisai EMEA
3 followers
At Eisai, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. We are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries. Our collective passion and dedication to patient care is the driving force behind our efforts to discover and develop innovative medicines in a variety of therapeutic areas in which a high unmet medical need remains, including oncology and neurology. Our mission is clear; we strive to make a significant long-lasting contribution to society in an ethical, compliant and sustainable way by embodying our hhc philosophy in everything we do. For more information about Eisai in the EMEA region please visit www.eisai.eu Our community guidelines can be found here: https://www.eisai.eu/wp-content/uploads/Community-guidelines-v1.0.pdf For more information about how Eisai processes your data, please refer to our privacy policy here: https://www.eisai.eu/privacy-policy/ --- November 2023 | EMEA-NON-23-00180